Jordi Xaus
Chief Tech/Sci/R&D Officer en ORYZON GENOMICS S.A. .
Perfil
Jordi Xaus is currently the Chief Scientific Officer at Oryzon Genomics SA since 2021.
Previously, he worked as the Director & Biomedicine Director at Biosearch SA. He also served as an Associate Professor at the University of Barcelona from 2000 to 2001.
Additionally, he held the position of Chief Scientific Officer at Palau Pharma SA. Dr. Xaus obtained a doctorate degree from the University of Barcelona in 1994, followed by a graduate degree in 1997.
He later earned another graduate degree from Ramon Llull University in 2009.
Cargos activos de Jordi Xaus
Empresas | Cargo | Inicio |
---|---|---|
ORYZON GENOMICS S.A. | Chief Tech/Sci/R&D Officer | 01/07/2021 |
Antiguos cargos conocidos de Jordi Xaus.
Empresas | Cargo | Fin |
---|---|---|
University of Barcelona | Corporate Officer/Principal | 01/01/2001 |
BIOSEARCH, S.A. | Director/Board Member | - |
Palau Pharma SA
Palau Pharma SA BiotechnologyHealth Technology Palau Pharma SA is a holding company engaged in the discovery and development of biophamaceuticals for the treatment of inflammatory and autoimmune diseases, such as rheumatoid arthritis, neuropathic pain, and chronic obstructive pulmonary disease. The company was founded on March 13, 1991 and is headquartered in Palau Solita i Plegamans, Spain. | Chief Tech/Sci/R&D Officer | - |
Formación de Jordi Xaus.
University of Barcelona | Doctorate Degree |
Ramon Llull University | Graduate Degree |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
ORYZON GENOMICS S.A. | Health Technology |
Empresas privadas | 2 |
---|---|
Biosearch SA
Biosearch SA Pharmaceuticals: OtherHealth Technology Biosearch SA engages in the provision of products for pharmaceutical, nutritional, and functional food sectors. It develops and markets three product platforms including Omega-3, Probiotics and Botanical Extracts. The company was founded on September 12, 2000 and is headquartered in Granada, Spain. | Health Technology |
Palau Pharma SA
Palau Pharma SA BiotechnologyHealth Technology Palau Pharma SA is a holding company engaged in the discovery and development of biophamaceuticals for the treatment of inflammatory and autoimmune diseases, such as rheumatoid arthritis, neuropathic pain, and chronic obstructive pulmonary disease. The company was founded on March 13, 1991 and is headquartered in Palau Solita i Plegamans, Spain. | Health Technology |
- Bolsa de valores
- Insiders
- Jordi Xaus